Biohaven stock slides on withdrawal of European marketing application
The drug, being developed for a rare genetic disorder and currently under review in the U.S., is seen by some investors as critical to Biohaven’s future.
Google Parent Alphabet’s Stock Climbs as Analysts Raise Targets on AI-Driven Growth
Shares of Google parent Alphabet climbed Friday as several analysts raised their price targets for the stock after the tech titan delivered better-than-expected quarterly results and touted the early success of AI features.
Gilead Sciences Stock Falls as Slumping COVID-19, Cancer Drug Sales Hit Revenue
Gilead Sciences missed first-quarter revenue estimates as sales of its COVID-19 and cancer drugs declined.
T-Mobile US Stock Sinks as Firm Posts Slow Phone Subscriber Growth
T-Mobile added fewer new phone customers than anticipated in the first quarter, sending shares lower.
World’s First Catastrophe-Bond ETF Falters in ‘Crazy’ Market
(Bloomberg) -- The world’s first-ever exchange-traded fund based on catastrophe bonds has failed to get the seed capital it expected after launching on the eve of the Trump administration’s tariff war.Most Read from BloombergTrump Gives New York ‘One Last Chance’ to End Congestion FeeWhy Car YouTuber Matt Farah Is Fighting for Walkable CitiesBackyard Micro-Flats Aim to Ease South Africa’s Housing CrisisThe Racial Wealth Gap Is Not Just About MoneyNewsom Says California Is Now the World’s Fourth-
Stock futures shed overnight gains, signaling weaker start to trading
Futures were up overnight, but lost steam early Friday as equities came under renewed selling pressure.
Keurig upgraded, Global Payments downgraded: Wall Street's top analyst calls
Keurig upgraded, Global Payments downgraded: Wall Street's top analyst calls
1 Semiconductor Stock Worth Your Attention and 2 to Keep Off Your Radar
Semiconductors are the silicon backbone of the digital revolution. Still, they’re subject to swings in the broader economy because customers often stockpile chips ahead of demand, and investors seem to believe that inventory levels are correcting - over the past six months, the industry has shed 24.2%. This drop was noticeably worse than the S&P 500’s 5.7% fall.
2 Cash-Producing Stocks with Exciting Potential and 1 to Think Twice About
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
3 Healthcare Stocks That Concern Us
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 10.9%. This drawdown was worse than the S&P 500’s 5.7% decline.